140
Participants
Start Date
April 9, 2018
Primary Completion Date
August 9, 2019
Study Completion Date
August 9, 2019
N-Acetylcysteine
In each patient recruited, assignation to placebo or N-Acetylcysteine group treatment wil be performed, after he/she has signed the informed consent. In the first visit, the evaluation by the psychiatrist and with the nurse team (structured evaluation, which includes the CCQ-N-10, CSSA, general health evaluation, urine drug test and basal blood screening), will be carried out. The nurse team will supervise the drug intake and they will observe 2 hours late the ADRs and general health status of patient, who will be responsible for the intake of the following medication doses. Each patient will be asked to attend twice week to his/her treatment center, during four weeks and each patient visit the clinical team will record the primary and secondary outcome.
Placebo oral capsule
In each patient recruited, assignation to placebo or N-Acetylcysteine group treatment wil be performed, after he/she has signed the informed consent. In the first visit, the evaluation by the psychiatrist and with the nurse team (structured evaluation, which includes the CCQ-N-10, CSSA, general health evaluation, urine drug test and basal blood screening), will be carried out. The nurse team will supervise the drug intake and they will observe 2 hours late the ADRs and general health status of patient, who will be responsible for the intake of the following medication doses. Each patient will be asked to attend twice week to his/her treatment center, during four weeks and each patient visit the clinical team will record the primary and secondary outcome.
Psychiatry Service of Hospital Guillermo Grant Benavente, Concepción
COSAM San Pedro de la Paz, San Pedro de la Paz
COSAM Lota, Lota
Therapeutic Community La Casa Chica, Talcahuano
Centro Terapéutico Anün, Coronel
Comisión Nacional de Investigación Científica y Tecnológica
OTHER_GOV
University of Concepcion, Chile
OTHER